Cite
Combined analysis of CSF βA42 peptide and tau protein and serum antibodies to glycosaminoglycans in Alzheimer's disease: preliminary data
MLA
L. Pasqui, et al. “Combined Analysis of CSF ΒA42 Peptide and Tau Protein and Serum Antibodies to Glycosaminoglycans in Alzheimer’s Disease: Preliminary Data.” Journal of Neural Transmission, vol. 109, Mar. 2002, pp. 393–98. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....33938c9faac69b98028c35babf849d62&authtype=sso&custid=ns315887.
APA
L. Pasqui, M. Naccarato, Chiara Briani, Annachiara Cagnin, S. Ruggero, Leontino Battistin, Gilberto Pizzolato, & Gianluigi Ricchieri. (2002). Combined analysis of CSF βA42 peptide and tau protein and serum antibodies to glycosaminoglycans in Alzheimer’s disease: preliminary data. Journal of Neural Transmission, 109, 393–398.
Chicago
L. Pasqui, M. Naccarato, Chiara Briani, Annachiara Cagnin, S. Ruggero, Leontino Battistin, Gilberto Pizzolato, and Gianluigi Ricchieri. 2002. “Combined Analysis of CSF ΒA42 Peptide and Tau Protein and Serum Antibodies to Glycosaminoglycans in Alzheimer’s Disease: Preliminary Data.” Journal of Neural Transmission 109 (March): 393–98. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....33938c9faac69b98028c35babf849d62&authtype=sso&custid=ns315887.